National Health Investors (NYSE:NHI) Announces Quarterly Earnings Results

National Health Investors (NYSE:NHI) announced its quarterly earnings results on Tuesday. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42), Zacks reports. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. During the same quarter last year, the firm posted $1.08 EPS. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. National Health Investors updated its FY24 guidance to $4.43-$4.44 EPS and its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Trading Up 3.8 %

NHI stock traded up $2.88 during trading on Thursday, hitting $79.64. The company had a trading volume of 451,097 shares, compared to its average volume of 194,790. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $3.46 billion, a P/E ratio of 27.07, a PEG ratio of 5.05 and a beta of 1.05. The company has a 50 day simple moving average of $80.38 and a 200-day simple moving average of $73.16. National Health Investors has a 52-week low of $49.25 and a 52-week high of $86.13.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.52%. National Health Investors’s dividend payout ratio is 122.45%.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Bank of America assumed coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Finally, Truist Financial raised their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $73.29.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.